{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:52:05Z","timestamp":1767135125681,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd011437","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000}}],"reference-count":82,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011437.pub2","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T10:02:50Z","timestamp":1437472970000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma"],"prefix":"10.1002","volume":"2015","author":[{"given":"David JW","family":"Evans","sequence":"first","affiliation":[{"name":"Royal Lancaster Infirmary; Lancaster Patient Safety Research Unit; Pointer Court 1, Ashton Road Lancaster UK LA1 4RP"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayleigh M","family":"Kew","sequence":"additional","affiliation":[{"name":"St George's, University of London; Population Health Research Institute; Cranmer Terrace London UK SW17 0RE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie E","family":"Anderson","sequence":"additional","affiliation":[{"name":"University of Strathclyde; Strathclyde Institute of Pharmacy and Biomedical Sciences; Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne C","family":"Boyter","sequence":"additional","affiliation":[{"name":"University of Strathclyde; Strathclyde Institute of Pharmacy and Biomedical Sciences; Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD011437.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4997\/JRCPE.2010.425","article-title":"Tiotropium bromide in asthma patients: an alternative to inhaled long-acting beta-agonists?","volume":"40","author":"Lane","year":"2010","journal-title":"Journal of the Royal College of Physicians of Edinburgh"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0002|cit2","unstructured":"NCT00565266 Asthma Clinical Research Network (ACRN) Trial - Tiotropium bromide as an alternative to increased inhaled corticosteroid in patients inadequately controlled on a lower dose of inhaled corticosteroid (TALC) http:\/\/clinicaltrials.gov\/show\/NCT00565266"},{"issue":"5","key":"10.1002\/14651858.CD011437.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaci.2013.08.003","article-title":"Predictors of response to tiotropium versus salmeterol in asthmatic adults","volume":"132","author":"Peters","year":"2013","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"18","key":"10.1002\/14651858.CD011437.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"s97","key":"10.1002\/14651858.CD011437.pub2-BIB0005|cit5","first-page":"376","article-title":"Once-daily add-on tiotropium: A dose-finding trial in adult patients with moderate persistent asthma [Abstract]","volume":"68","author":"Beeh","year":"2013","journal-title":"Allergy"},{"issue":"4 Meeting Abstr","key":"10.1002\/14651858.CD011437.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"89A","DOI":"10.1378\/chest.1701649","article-title":"Once-daily tiotropium is well tolerated as add-on to standard treatment for patients with symptomatic asthma despite receiving inhaled corticosteroids and long-acting beta2-agonists [Abstract]","volume":"144","author":"Bernstein","year":"2013","journal-title":"Chest"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD011437.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"AB5","DOI":"10.1016\/j.jaci.2013.12.040","article-title":"Tiotropium Respimat add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of TH2 inflammatory status [Abstract]","volume":"133","author":"Casale","year":"2014","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"Suppl 97","key":"10.1002\/14651858.CD011437.pub2-BIB0008|cit8","first-page":"377","article-title":"Phase III trials to investigate tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: trial design and planned statistical analyses [Abstract]","volume":"68","author":"Casale","year":"2013","journal-title":"Allergy"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0009|cit9","first-page":"S157","article-title":"Once-daily tiotropium respimat decreases the risk of exacerbations, independent of baseline characteristics, in patients with symptomatic severe asthma without evidence of chronic obstructive pulmonary disease","volume":"29","author":"Corren","year":"2014","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0010|cit10","unstructured":"CTRI\/2008\/091\/000306 A randomized, double-blind, crossover, non-inferiority study comparing bronchodilator effects of single dose of 18 mcg of Tiotropium Bromide and two doses of 12 mcg of formoterol fumarate each over 24 hours in subjects with moderate to severe asthma http:\/\/www.ctri.nic.in\/Clinicaltrials\/pdf_generate.php?trialid=284&EncHid=&modid=&compid=%27,%27284det%27"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0011|cit11","unstructured":"CTRI\/2012\/08\/002915 Assessment of various second line treatment regimens on mild to moderate persistent asthmatic patients http:\/\/www.ctri.nic.in\/Clinicaltrials\/pdf_generate.php?trialid=5059&EncHid=&modid=&compid=%27,%275059det%27"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD011437.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"AB5","DOI":"10.1016\/j.jaci.2013.12.041","article-title":"Once-daily tiotropium respimat improves lung function in patients with severe symptomatic asthma independent of leukotriene modifier use [Abstract]","volume":"133","author":"Dahl","year":"2014","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0013|cit13","unstructured":"Dahl R Bateman ED Casale TB Pizzichini E Vandewalker M Virchow JC Once-daily tiotropium Respimat as add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status [Abstract] 33rd Congress of the European Academy of Allergy and Clinical Immunology; 2014 June 7-11; Copenhagen 2014"},{"issue":"4 Meeting Abstr","key":"10.1002\/14651858.CD011437.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"88A","DOI":"10.1378\/chest.1702143","article-title":"Improvements in lung function with tiotropium as add-on controller therapy to ICS+LABA for patients with symptomatic severe asthma [Abstract]","volume":"144","author":"Doherty","year":"2013","journal-title":"Chest"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0015|cit15","unstructured":"EUCTR2006-003385-34-NL The effect of tiotropium-bromide on deep inspiration-induced bronchodilation and airway responsiveness in asthma https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2006-003385-34\/NL\/#A"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011437.pub2-BIB0016|cit16","first-page":"ii72","article-title":"Stepping down inhaled steroids in severe asthma with long acting bronchodilators: utilising effort dependent and independent measures of pulmonary function [Abstract]","volume":"59","author":"Haggart","year":"2004","journal-title":"Thorax"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011437.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"A149","DOI":"10.1136\/thoraxjnl-2013-204457.314","article-title":"Tiotropium decreases the risk of exacerbations in patients with symptomatic asthma regardless of baseline characteristics including markers of allergic status [Abstract]","volume":"68","author":"Halpin","year":"2013","journal-title":"Thorax"},{"issue":"S4","key":"10.1002\/14651858.CD011437.pub2-BIB0018|cit18","first-page":"175","article-title":"Tiotropium decreases the risk of exacerbations in patients with symptomatic asthma regardless of baseline characteristics [Abstract]","volume":"18","author":"Hozawa","year":"2013","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0019|cit19","unstructured":"JPRN-UMIN000010352 Study for effects of tiotropium on smokers and non-smokers with bronchial asthma http:\/\/www.umin.ac.jp\/ctr\/index.htm"},{"issue":"4 Meeting Abstr","key":"10.1002\/14651858.CD011437.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"91A","DOI":"10.1378\/chest.1702134","article-title":"Tiotropium as add-on therapy to ICS+LABA in patients with symptomatic severe asthma: spirometric assessment over 24 hours [Abstract]","volume":"144","author":"Corren","year":"2013","journal-title":"Chest"},{"issue":"13","key":"10.1002\/14651858.CD011437.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD011437.pub2-BIB0022|cit22","first-page":"AB1","article-title":"Efficacy of tiotropium in patients with asthma in relation to allergic status [Abstract]","volume":"131","author":"Vandewalker","year":"2013","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD011437.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2011.06.004","article-title":"Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg\/Arg patients with asthma","volume":"128","author":"Bateman","year":"2011","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0024|cit24","unstructured":"NCT00350207 A 16-week randomised, placebo-controlled, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of tiotropium inhalation solution delivered by the Respimat inhaler (2 actuations of 2.5 mcg once daily) with that of salmeterol from the hydrofluoroalkane metered dose inhaler (2 actuations of 25 mcg twice daily) in moderate persistent asthma patients with the B16-Arg\/Arg genotype http:\/\/clinicaltrials.gov\/show\/NCT00350207"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0025|cit25","unstructured":"NCT00557180 Obesity, Inflammation and Response to Therapy in Asthma - Ancillary to Asthma Clinical Research Network (ACRN) Trials https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00557180"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0026|cit26","unstructured":"NCT00706446 Genotype stratified treatment with anticholinergic vs. beta-agonist (long acting) and exacerbations (GABLE) http:\/\/clinicaltrials.gov\/show\/NCT00706446"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0027|cit27","unstructured":"NCT01172808 A phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat\u00ae inhaler (2.5 and 5 \u00b5g once daily) compared with placebo and salmeterol HFA MDI (50 \u00b5g twice daily) over 24 weeks in moderate persistent asthma http:\/\/clinicaltrials.gov\/show\/NCT01172808"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0028|cit28","unstructured":"NCT01172821 A Phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat\u00ae inhaler (2.5 and 5 \u00b5g once daily) compared with placebo and salmeterol HFA MDI (50 \u00b5g Twice Daily) over 24 weeks in moderate persistent asthma http:\/\/clinicaltrials.gov\/show\/NCT01172821"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0029|cit29","unstructured":"NCT01290874 Blacks and Exacerbations on LABA vs. Tiotropium (BELT) http:\/\/clinicaltrials.gov\/show\/NCT01290874"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0030|cit30","unstructured":"NCT01316380 A Phase III, randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat\u00ae inhaler (2.5 ug and 5 ug once daily) compared to placebo over 12 weeks in mild persistent asthma http:\/\/clinicaltrials.gov\/show\/NCT01316380"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0031|cit31","unstructured":"NCT01340209 A Phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate safety and efficacy of tiotropium inhalation solution delivered via Respimat inhaler (2.5 and 5 \u00b5g Once Daily) compared with placebo over 52 weeks in patients with moderate to severe persistent asthma http:\/\/clinicaltrials.gov\/show\/NCT01340209"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0032|cit32","unstructured":"NCT01573624 A multi-center, randomized, double-blind, dose-ranging study to evaluate GSK573719 in combination with fluticasone furoate, fluticasone furoate alone, and an active control of fluticasone furoate\/vilanterol combination in subjects with asthma http:\/\/clinicaltrials.gov\/show\/NCT01573624"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0033|cit33","unstructured":"NCT01641692 A multi-national, randomized, double-blind, placebo-controlled, 3-period crossover study with GSK 573719 as monotherapy in adult subjects with asthma http:\/\/clinicaltrials.gov\/show\/NCT01641692"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0034|cit34","unstructured":"NCT01696214 SAPS: smoking asthmatics pilot study http:\/\/clinicaltrials.gov\/show\/NCT01696214"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0035|cit35","unstructured":"NCT02127697 A randomized, double-blind, parallel group, 52-week study evaluating the efficacy, safety and tolerability of NVA237 in patients with poorly controlled asthma http:\/\/clinicaltrials.gov\/show\/NCT02127697"},{"issue":"Suppl 57","key":"10.1002\/14651858.CD011437.pub2-BIB0036|cit36","first-page":"877s [P4133]","article-title":"Phase III trial of tiotropium as add-on therapy to low-dose inhaled corticosteroids for patients with symptomatic mild persistent asthma: Design and planned analyses [Abstract]","volume":"42","author":"Paggiaro","year":"2013","journal-title":"European Respiratory Journal"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD011437.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"AB4","DOI":"10.1016\/j.jaci.2013.12.039","article-title":"Tiotropium respimat add-on to inhaled corticosteroids improves lung function in patients with symptomatic mild asthma: Results from a phase III trial","volume":"133","author":"Paggiaro","year":"2014","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"7","key":"10.1002\/14651858.CD011437.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/1440-1681.12239","article-title":"Assessment of various second-line medications in addition to inhaled corticosteroid in asthma patients: a randomized controlled trial","volume":"41","author":"Rajanandh","year":"2014","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"4","key":"10.1002\/14651858.CD011437.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.clinthera.2014.02.006","article-title":"Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline, and tiotropium with budesonide: a randomized controlled study","volume":"36","author":"Rajanandh","year":"2014","journal-title":"Clinical Therapeutics"},{"issue":"4 Meeting Abstr","key":"10.1002\/14651858.CD011437.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"90A","DOI":"10.1378\/chest.1701739","article-title":"Once-daily tiotropium reduces risk of exacerbations and asthma worsening in patients with symptomatic asthma despite treatment with inhaled corticosteroids and long-acting beta2-agonists [Abstract]","volume":"144","author":"Tashkin","year":"2013","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011437.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"O5","DOI":"10.1186\/2045-7022-4-S1-O5","article-title":"Once-daily tiotropium in adolescents with symptomatic asthma despite inhaled corticosteroid treatment: a dose-ranging study [Abstract]","volume":"4","author":"Vogelberg","year":"2014","journal-title":"Clinical and Translational Allergy"},{"issue":"1","key":"10.1002\/14651858.CD011437.pub2-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002738.pub2","article-title":"Beclomethasone versus placebo for chronic asthma","author":"Adams","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011437.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003135.pub4","article-title":"Fluticasone versus placebo for chronic asthma in adults and children","author":"Adams","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD011437.pub2-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011397","article-title":"Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS for adults with asthma","author":"Allison","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.330.7499.1037","article-title":"Prevalence of asthma","volume":"330","author":"Anderson","year":"2005","journal-title":"British Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD011437.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The gaining optimal asthma control study","volume":"170","author":"Bateman","year":"2004","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0047|cit47","first-page":"11","article-title":"Tiotropium in asthma: a systematic review","volume":"7","author":"Befekadu","year":"2014","journal-title":"Journal of Asthma and Allergy"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0048|cit48","unstructured":"Royal Pharmaceutical Society British National Formulary (online) http:\/\/www.medicinescomplete.com"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0049|cit49","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GradePro Version 3.2 for Windows 2008"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD011437.pub2-BIB0050|cit50","first-page":"i1","article-title":"British guideline on the management of asthma","volume":"69","author":"British Thoracic Society","year":"2014","journal-title":"Thorax"},{"issue":"1","key":"10.1002\/14651858.CD011437.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003137.pub5","article-title":"Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma","author":"Chauhan","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0052|cit52","unstructured":"Chinchilli VM Allocation concealment used in our trial [personal communication] Email to: D Evans."},{"issue":"9","key":"10.1002\/14651858.CD011437.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009157.pub2","article-title":"Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease","author":"Chong","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0054|cit54","unstructured":"The Alfred Hospital Monash University National ICT Australia and the University of London Covidence 2013"},{"issue":"1","key":"10.1002\/14651858.CD011437.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0091-6749(96)70221-X","article-title":"Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study","volume":"98","author":"Blic","year":"1996","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1002\/14651858.CD011437.pub2-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005535.pub2","article-title":"Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children","author":"Ducharme","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011437.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005533.pub2","article-title":"Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma","author":"Ducharme","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011437.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0059|cit59","unstructured":"Electronic Medicines Compendium (eMC) License extension 19th September 2014: Spiriva Respimat 2.5 micrograms solution for inhalation https:\/\/www.medicines.org.uk\/emc\/history\/20134"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0060|cit60","unstructured":"Global Initiative for Asthma Global Strategy For Asthma Management And Prevention http:\/\/www.ginasthma.org\/documents\/4"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0061|cit61","unstructured":"International Union Against Tuberculosis and Lung Disease The Global Asthma Report 2014 The Global Asthma Report 2014, http:\/\/www.globalasthmareport.org"},{"issue":"1","key":"10.1002\/14651858.CD011437.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1465-9921-7-73","article-title":"Muscarinic receptor signaling in the pathophysiology of asthma and COPD","volume":"7","author":"Gosens","year":"2006","journal-title":"Respiratory Research"},{"issue":"11","key":"10.1002\/14651858.CD011437.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199409153311103","article-title":"Effects of reducing or discontinuing inhaled budesonide inpatients with mild asthma","volume":"331","author":"Haahtela","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0064|cit64","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD011437.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0091-6749(91)90006-A","article-title":"Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained","volume":"87","author":"Juniper","year":"1991","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD011437.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2005.08.012","article-title":"Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire","volume":"100","author":"Juniper","year":"2006","journal-title":"Respiratory Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011437.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009285.pub3","article-title":"Tiotropium versus placebo for chronic obstructive pulmonary disease","author":"Karner","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD011437.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011438.pub2","article-title":"Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma","author":"Kew","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011437.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/bcp.12123","article-title":"Emerging role of long acting muscarinic antagonists for asthma","volume":"77","author":"Lipworth","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0070|cit70","unstructured":"Chandler J Churchill R Higgins J LassersonT Tovey D Methodological Expectations for the conduct of Cochrane Intervention Review, version 2.3 http:\/\/editorial-unit.cochrane.org\/mecir."},{"issue":"1","key":"10.1002\/14651858.CD011437.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1476-5381.2010.01190.x","article-title":"Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD","volume":"163","author":"Moulton","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD011437.pub2-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010509.pub2","article-title":"Aclidinium bromide for stable chronic obstructive pulmonary disease","author":"Ni","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0073|cit73","unstructured":"National Institute for Health and Care Excellence NICE advice [KTT5] High-dose inhaled corticosteroids in asthma http:\/\/www.nice.org.uk\/Advice\/ktt5"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0074|cit74","volume-title":"Why Asthma Still Kills: The National Review of Asthma Deaths (NRAD) Confidential Enquiry Report","author":"Royal College of Physicians","year":"2014"},{"issue":"5","key":"10.1002\/14651858.CD011437.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/SMJ.0000000000000108","article-title":"Tiotropium in the treatment of patients with asthma","volume":"107","author":"Rashid","year":"2014","journal-title":"Southern Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD011437.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/14651858.CD011437.pub2-BIB0077|cit77","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD011437.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1378\/chest.14-1698","article-title":"What is the role of tiotropium in asthma?: A systematic review with meta-analysis","volume":"147","author":"Rodrigo","year":"2015","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD011437.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001281.pub2","article-title":"Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma","author":"Tee","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011437.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1183\/09031936.00005813","article-title":"Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patient with COPD","volume":"42","author":"Verhamme","year":"2013","journal-title":"European Respiratory Journal"},{"issue":"16","key":"10.1002\/14651858.CD011437.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa1303342","article-title":"Tiotropium Respimat Inhaler and the risk of death in COPD","volume":"369","author":"Wise","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD011437.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011437","article-title":"Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma","author":"Kew","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD011437.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T23:22:38Z","timestamp":1717975358000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011437.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":82,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011437.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,21]]}}}